Award

Modulating stem cell differentiation in individuals with high risk clonal haematopoiesis: the MOSAIC trial

Description: Throughout life, our blood stem cells acquire mutations in their genes. Some mutations allow those stem cells to dominate blood cell production, a phenomenon called clonal haematopoiesis. Many complications of ageing, including blood cancers, heart disease, and infections, are connected to these mutations. We will attempt to reverse the effects of these mutations using a new treatment we developed to restore normal stem cell production, with the goal of preventing the complications of ageing.
Amount: A$2,972,000
Funding type: research
Funder scheme: Medical Research Future Fund
Start date: 2023-02-01
End date: 2028-01-31
Subfield: Hematology
Field: Medicine
Funded outputs count: 0
Funder award ID: GA289071
OpenAlex ID: G7380120186